| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2022 | Jun 10, 2022 | ROSS STORES, INC. | Director | Sell | 22.5 | -1,000 | -2.82% | ✗ | $81.5K |
| Jun 11, 2018 | Jun 12, 2018 | ROSS STORES, INC. | Director | Sell | 22.5 | -1,500 | -4.75% | ✗ | $128.6K |
| Mar 30, 2017 | Apr 3, 2017 | ROSS STORES, INC. | Director | Sell | 20.0 | -8,762 | -24.22% | ✗ | $582.7K |
| Mar 23, 2017 | Mar 27, 2017 | ROSS STORES, INC. | Director | Sell | 20.0 | -7,426 | -11.93% | ✗ | $493.9K |
| Mar 4, 2016 | Mar 8, 2016 | ROSS STORES, INC. | Director | Sell | 20.0 | -16,188 | -39.46% | ✗ | $932K |
| Sep 9, 2015 | Sep 10, 2015 | ROSS STORES, INC. | Director | Sell | 20.0 | -15,000 | -37.65% | ✗ | $751.5K |
| Mar 2, 2015 | Mar 4, 2015 | ROSS STORES, INC. | Director | Sell | 17.5 | -36,760 | -40.71% | ✗ | $3.9M |
| Apr 10, 2014 | Apr 11, 2014 | ROSS STORES, INC. | Director | Sell | 45.0 | -57 | -0.23% | ✗ | $4K |
| Jun 29, 2012 | Apr 8, 2014 | ROSS STORES, INC. | Director | Buy | 60.0 | +57 | 0.25% | ✗ | $3.5K |
| Apr 2, 2014 | Apr 3, 2014 | ROSS STORES, INC. | Director | Sell | 17.5 | -16,000 | -39.10% | ✗ | $1.2M |
| Mar 25, 2013 | Mar 27, 2013 | ROSS STORES, INC. | Director | Sell | 20.0 | -16,000 | -41.08% | ✗ | $945.9K |
| Dec 17, 2010 | Dec 20, 2010 | Ernexa Therapeutics Inc. | CEO | Buy | 95.0 | +150,000 | 99.68% | ✗ | $51K |
| Sep 8, 2010 | Sep 9, 2010 | Ernexa Therapeutics Inc. | CEO | Buy | 91.3 | +31,800 | 26.80% | ✗ | $12K |
| Aug 17, 2010 | Aug 18, 2010 | Ernexa Therapeutics Inc. | CEO | Buy | 90.0 | +20,000 | 20.27% | ✗ | $8.2K |
| Jun 9, 2010 | Jun 10, 2010 | Ernexa Therapeutics Inc. | CEO | Buy | 67.5 | +600 | 0.61% | ✗ | $288 |
| Jun 2, 2010 | Jun 3, 2010 | Ernexa Therapeutics Inc. | CEO | Buy | 90.0 | +10,000 | 11.35% | ✗ | $5.2K |
| May 27, 2010 | Jun 1, 2010 | Ernexa Therapeutics Inc. | CEO | Buy | 60.0 | +200 | 0.23% | ✗ | $110 |
| May 25, 2010 | May 26, 2010 | Ernexa Therapeutics Inc. | CEO | Buy | 90.0 | +11,200 | 14.61% | ✗ | $6.4K |
| May 19, 2010 | May 21, 2010 | Ernexa Therapeutics Inc. | CEO | Buy | 91.3 | +21,700 | 39.47% | ✗ | $10.3K |
| May 18, 2010 | May 19, 2010 | Ernexa Therapeutics Inc. | CEO | Buy | 91.3 | +20,000 | 57.18% | ✗ | $11.5K |
| Nov 23, 2009 | Nov 24, 2009 | Ernexa Therapeutics Inc. | Director | Buy | 90.0 | +3,975 | 12.82% | ✗ | $2.1K |
| Nov 18, 2009 | Nov 19, 2009 | Ernexa Therapeutics Inc. | Director | Buy | 90.0 | +11,000 | 55.00% | ✗ | $5.4K |
| Sep 17, 2009 | Sep 18, 2009 | Ernexa Therapeutics Inc. | Director | Buy | 90.0 | +4,000 | 25.00% | ✗ | $2.1K |